IBDEI066 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8036,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8036,1,1,0)
 ;;=1^163.9
 ;;^UTILITY(U,$J,358.3,8036,1,8,0)
 ;;=8^Pleura
 ;;^UTILITY(U,$J,358.3,8036,2)
 ;;=^267140
 ;;^UTILITY(U,$J,358.3,8037,0)
 ;;=170.9^^45^468^3
 ;;^UTILITY(U,$J,358.3,8037,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8037,1,1,0)
 ;;=1^170.9
 ;;^UTILITY(U,$J,358.3,8037,1,8,0)
 ;;=8^Bone Sarcoma
 ;;^UTILITY(U,$J,358.3,8037,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,8038,0)
 ;;=194.0^^45^468^1
 ;;^UTILITY(U,$J,358.3,8038,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8038,1,1,0)
 ;;=1^194.0
 ;;^UTILITY(U,$J,358.3,8038,1,8,0)
 ;;=8^Adrenal Gland
 ;;^UTILITY(U,$J,358.3,8038,2)
 ;;=^267298
 ;;^UTILITY(U,$J,358.3,8039,0)
 ;;=173.91^^45^468^2
 ;;^UTILITY(U,$J,358.3,8039,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8039,1,1,0)
 ;;=1^173.91
 ;;^UTILITY(U,$J,358.3,8039,1,8,0)
 ;;=8^BCC Skin
 ;;^UTILITY(U,$J,358.3,8039,2)
 ;;=^340491
 ;;^UTILITY(U,$J,358.3,8040,0)
 ;;=173.99^^45^468^7
 ;;^UTILITY(U,$J,358.3,8040,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8040,1,1,0)
 ;;=1^173.99
 ;;^UTILITY(U,$J,358.3,8040,1,8,0)
 ;;=8^Oth Spec Skin
 ;;^UTILITY(U,$J,358.3,8040,2)
 ;;=^340493
 ;;^UTILITY(U,$J,358.3,8041,0)
 ;;=173.92^^45^468^10
 ;;^UTILITY(U,$J,358.3,8041,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8041,1,1,0)
 ;;=1^173.92
 ;;^UTILITY(U,$J,358.3,8041,1,8,0)
 ;;=8^SCC Skin
 ;;^UTILITY(U,$J,358.3,8041,2)
 ;;=^340492
 ;;^UTILITY(U,$J,358.3,8042,0)
 ;;=173.90^^45^468^11
 ;;^UTILITY(U,$J,358.3,8042,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8042,1,1,0)
 ;;=1^173.90
 ;;^UTILITY(U,$J,358.3,8042,1,8,0)
 ;;=8^Skin, Unspec
 ;;^UTILITY(U,$J,358.3,8042,2)
 ;;=^340605
 ;;^UTILITY(U,$J,358.3,8043,0)
 ;;=198.7^^45^469^1
 ;;^UTILITY(U,$J,358.3,8043,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8043,1,1,0)
 ;;=1^198.7
 ;;^UTILITY(U,$J,358.3,8043,1,8,0)
 ;;=8^Adrenal Metastasis
 ;;^UTILITY(U,$J,358.3,8043,2)
 ;;=^267337
 ;;^UTILITY(U,$J,358.3,8044,0)
 ;;=198.5^^45^469^2
 ;;^UTILITY(U,$J,358.3,8044,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8044,1,1,0)
 ;;=1^198.5
 ;;^UTILITY(U,$J,358.3,8044,1,8,0)
 ;;=8^Bone/Bone Marrow Mestastasis
 ;;^UTILITY(U,$J,358.3,8044,2)
 ;;=^267336
 ;;^UTILITY(U,$J,358.3,8045,0)
 ;;=198.3^^45^469^3
 ;;^UTILITY(U,$J,358.3,8045,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8045,1,1,0)
 ;;=1^198.3
 ;;^UTILITY(U,$J,358.3,8045,1,8,0)
 ;;=8^Brain Metastasis
 ;;^UTILITY(U,$J,358.3,8045,2)
 ;;=^267334
 ;;^UTILITY(U,$J,358.3,8046,0)
 ;;=198.4^^45^469^4
 ;;^UTILITY(U,$J,358.3,8046,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8046,1,1,0)
 ;;=1^198.4
 ;;^UTILITY(U,$J,358.3,8046,1,8,0)
 ;;=8^Leptomeningeal Metastasis
 ;;^UTILITY(U,$J,358.3,8046,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,8047,0)
 ;;=197.7^^45^469^5
 ;;^UTILITY(U,$J,358.3,8047,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8047,1,1,0)
 ;;=1^197.7
 ;;^UTILITY(U,$J,358.3,8047,1,8,0)
 ;;=8^Liver Metastasis
 ;;^UTILITY(U,$J,358.3,8047,2)
 ;;=^267328
 ;;^UTILITY(U,$J,358.3,8048,0)
 ;;=197.0^^45^469^6
 ;;^UTILITY(U,$J,358.3,8048,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8048,1,1,0)
 ;;=1^197.0
 ;;^UTILITY(U,$J,358.3,8048,1,8,0)
 ;;=8^Lung Metastasis
 ;;^UTILITY(U,$J,358.3,8048,2)
 ;;=^267322
 ;;^UTILITY(U,$J,358.3,8049,0)
 ;;=196.2^^45^469^7
 ;;^UTILITY(U,$J,358.3,8049,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8049,1,1,0)
 ;;=1^196.2
 ;;^UTILITY(U,$J,358.3,8049,1,8,0)
 ;;=8^Lymph Nodes, Abdominal
 ;;^UTILITY(U,$J,358.3,8049,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,8050,0)
 ;;=196.3^^45^469^8
 ;;^UTILITY(U,$J,358.3,8050,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8050,1,1,0)
 ;;=1^196.3
 ;;^UTILITY(U,$J,358.3,8050,1,8,0)
 ;;=8^Lymph Nodes,Axillary & Upper Limb
 ;;^UTILITY(U,$J,358.3,8050,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,8051,0)
 ;;=196.0^^45^469^9
 ;;^UTILITY(U,$J,358.3,8051,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8051,1,1,0)
 ;;=1^196.0
 ;;^UTILITY(U,$J,358.3,8051,1,8,0)
 ;;=8^Lymph Nodes,Cervical,Hd,Face,Neck
 ;;^UTILITY(U,$J,358.3,8051,2)
 ;;=^267314
 ;;^UTILITY(U,$J,358.3,8052,0)
 ;;=196.1^^45^469^10
 ;;^UTILITY(U,$J,358.3,8052,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8052,1,1,0)
 ;;=1^196.1
 ;;^UTILITY(U,$J,358.3,8052,1,8,0)
 ;;=8^Lymph Nodes,Intrathoracic
 ;;^UTILITY(U,$J,358.3,8052,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,8053,0)
 ;;=196.8^^45^469^11
 ;;^UTILITY(U,$J,358.3,8053,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8053,1,1,0)
 ;;=1^196.8
 ;;^UTILITY(U,$J,358.3,8053,1,8,0)
 ;;=8^Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,8053,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,8054,0)
 ;;=198.2^^45^469^12
 ;;^UTILITY(U,$J,358.3,8054,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8054,1,1,0)
 ;;=1^198.2
 ;;^UTILITY(U,$J,358.3,8054,1,8,0)
 ;;=8^Secondary Malig Neo Skin
 ;;^UTILITY(U,$J,358.3,8054,2)
 ;;=^267333
 ;;^UTILITY(U,$J,358.3,8055,0)
 ;;=V65.3^^45^470^4
 ;;^UTILITY(U,$J,358.3,8055,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8055,1,1,0)
 ;;=1^V65.3
 ;;^UTILITY(U,$J,358.3,8055,1,8,0)
 ;;=8^Dietary Surveil/Counseling
 ;;^UTILITY(U,$J,358.3,8055,2)
 ;;=^295563
 ;;^UTILITY(U,$J,358.3,8056,0)
 ;;=V79.1^^45^470^1
 ;;^UTILITY(U,$J,358.3,8056,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8056,1,1,0)
 ;;=1^V79.1
 ;;^UTILITY(U,$J,358.3,8056,1,8,0)
 ;;=8^Alcoholism Screening
 ;;^UTILITY(U,$J,358.3,8056,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,8057,0)
 ;;=V79.0^^45^470^3
 ;;^UTILITY(U,$J,358.3,8057,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8057,1,1,0)
 ;;=1^V79.0
 ;;^UTILITY(U,$J,358.3,8057,1,8,0)
 ;;=8^Depression Screening
 ;;^UTILITY(U,$J,358.3,8057,2)
 ;;=^295677
 ;;^UTILITY(U,$J,358.3,8058,0)
 ;;=V65.49^^45^470^7
 ;;^UTILITY(U,$J,358.3,8058,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8058,1,1,0)
 ;;=1^V65.49
 ;;^UTILITY(U,$J,358.3,8058,1,8,0)
 ;;=8^Medication Counseling
 ;;^UTILITY(U,$J,358.3,8058,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,8059,0)
 ;;=V66.2^^45^470^2
 ;;^UTILITY(U,$J,358.3,8059,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8059,1,1,0)
 ;;=1^V66.2
 ;;^UTILITY(U,$J,358.3,8059,1,8,0)
 ;;=8^Chemotherapy Convalescen
 ;;^UTILITY(U,$J,358.3,8059,2)
 ;;=^295568
 ;;^UTILITY(U,$J,358.3,8060,0)
 ;;=V76.10^^45^470^8
 ;;^UTILITY(U,$J,358.3,8060,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8060,1,1,0)
 ;;=1^V76.10
 ;;^UTILITY(U,$J,358.3,8060,1,8,0)
 ;;=8^Screen Mal Neop-Breast,Unsp
 ;;^UTILITY(U,$J,358.3,8060,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,8061,0)
 ;;=V76.2^^45^470^9
 ;;^UTILITY(U,$J,358.3,8061,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8061,1,1,0)
 ;;=1^V76.2
 ;;^UTILITY(U,$J,358.3,8061,1,8,0)
 ;;=8^Screen Mal Neop-Cervix
 ;;^UTILITY(U,$J,358.3,8061,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,8062,0)
 ;;=V76.41^^45^470^10
 ;;^UTILITY(U,$J,358.3,8062,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8062,1,1,0)
 ;;=1^V76.41
 ;;^UTILITY(U,$J,358.3,8062,1,8,0)
 ;;=8^Screen Mal Neop-Rectum
 ;;^UTILITY(U,$J,358.3,8062,2)
 ;;=^295655
 ;;^UTILITY(U,$J,358.3,8063,0)
 ;;=V26.33^^45^470^6
 ;;^UTILITY(U,$J,358.3,8063,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8063,1,1,0)
 ;;=1^V26.33
 ;;^UTILITY(U,$J,358.3,8063,1,8,0)
 ;;=8^Genetic Counseling
 ;;^UTILITY(U,$J,358.3,8063,2)
 ;;=^332865
 ;;^UTILITY(U,$J,358.3,8064,0)
 ;;=V58.11^^45^470^5
 ;;^UTILITY(U,$J,358.3,8064,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8064,1,1,0)
 ;;=1^V58.11
 ;;^UTILITY(U,$J,358.3,8064,1,8,0)
 ;;=8^Encounter for Chemotherapy
 ;;^UTILITY(U,$J,358.3,8064,2)
 ;;=^332869
 ;;^UTILITY(U,$J,358.3,8065,0)
 ;;=282.60^^45^471^6
 ;;^UTILITY(U,$J,358.3,8065,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8065,1,1,0)
 ;;=1^282.60
 ;;^UTILITY(U,$J,358.3,8065,1,8,0)
 ;;=8^Sickle-Cell Anemia Nos
 ;;^UTILITY(U,$J,358.3,8065,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,8066,0)
 ;;=282.62^^45^471^3
 ;;^UTILITY(U,$J,358.3,8066,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8066,1,1,0)
 ;;=1^282.62
 ;;^UTILITY(U,$J,358.3,8066,1,8,0)
 ;;=8^Hb-S Disease With Crisis
 ;;^UTILITY(U,$J,358.3,8066,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,8067,0)
 ;;=282.61^^45^471^2
 ;;^UTILITY(U,$J,358.3,8067,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8067,1,1,0)
 ;;=1^282.61
 ;;^UTILITY(U,$J,358.3,8067,1,8,0)
 ;;=8^Hb-S Disease W/O Crisis
 ;;^UTILITY(U,$J,358.3,8067,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,8068,0)
 ;;=282.69^^45^471^5
 ;;^UTILITY(U,$J,358.3,8068,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8068,1,1,0)
 ;;=1^282.69
 ;;^UTILITY(U,$J,358.3,8068,1,8,0)
 ;;=8^Other Sickle Cell Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,8068,2)
 ;;=^87863
 ;;^UTILITY(U,$J,358.3,8069,0)
 ;;=282.5^^45^471^7
 ;;^UTILITY(U,$J,358.3,8069,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8069,1,1,0)
 ;;=1^282.5
 ;;^UTILITY(U,$J,358.3,8069,1,8,0)
 ;;=8^Sickle-Cell Trait
 ;;^UTILITY(U,$J,358.3,8069,2)
 ;;=^110419
 ;;^UTILITY(U,$J,358.3,8070,0)
 ;;=282.63^^45^471^8
 ;;^UTILITY(U,$J,358.3,8070,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8070,1,1,0)
 ;;=1^282.63
 ;;^UTILITY(U,$J,358.3,8070,1,8,0)
 ;;=8^Sickle-Cell/Hb-C Disease
 ;;^UTILITY(U,$J,358.3,8070,2)
 ;;=^267983
 ;;^UTILITY(U,$J,358.3,8071,0)
 ;;=282.41^^45^471^10
 ;;^UTILITY(U,$J,358.3,8071,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8071,1,1,0)
 ;;=1^282.41
 ;;^UTILITY(U,$J,358.3,8071,1,8,0)
 ;;=8^Thalassemias
 ;;^UTILITY(U,$J,358.3,8071,2)
 ;;=^329908
 ;;^UTILITY(U,$J,358.3,8072,0)
 ;;=282.49^^45^471^9
 ;;^UTILITY(U,$J,358.3,8072,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8072,1,1,0)
 ;;=1^282.49
 ;;^UTILITY(U,$J,358.3,8072,1,8,0)
 ;;=8^Thalassemia NEC
 ;;^UTILITY(U,$J,358.3,8072,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,8073,0)
 ;;=288.09^^45^471^1
 ;;^UTILITY(U,$J,358.3,8073,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8073,1,1,0)
 ;;=1^288.09
 ;;^UTILITY(U,$J,358.3,8073,1,8,0)
 ;;=8^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,8073,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,8074,0)
 ;;=289.4^^45^471^4
 ;;^UTILITY(U,$J,358.3,8074,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,8074,1,1,0)
 ;;=1^289.4
 ;;^UTILITY(U,$J,358.3,8074,1,8,0)
 ;;=8^Hypersplenism
